Roos E. Barth

579 citations

22 papers · 363 indexed · h-index 11

Impact in

Virology top 5%
- HIV Research and Treatment
Emergency Medicine top 5%
- HIV-related health complications and treatments

Papers in ⓘ

Infectious Diseases 12
- HIV/AIDS Research and Interventions 10
- HIV/AIDS drug development and treatment 7
Emergency Medicine 12
- HIV-related health complications and treatments 12

Co-authors: Kerstin Klipstein‐Grobusch (15 shared papers)Diederick E. Grobbee (14 shared papers)Alinda G. Vos (15 shared papers)Andy I. M. Hoepelman (5 shared papers)Hugo A. Tempelman (9 shared papers)Nikmah S. Idris (1 shared paper)Annemarie M. J. Wensing (4 shared papers)Rob Schuurman (3 shared papers)
Journals: PLoS ONE (4 papers)Retrovirology (2 papers)Antiviral Therapy (2 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)Scientific Reports (1 paper)
Partner nations: Netherlands South Africa United States

In The Last Decade

Roos E. Barth

20 papers receiving 359 citations

Peers

Countries citing papers authored by Roos E. Barth

Since Specialization

Citations

This map shows the geographic impact of Roos E. Barth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roos E. Barth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roos E. Barth more than expected).

Fields of papers citing papers by Roos E. Barth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roos E. Barth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roos E. Barth. The network helps show where Roos E. Barth may publish in the future.

Co-authors

The 25 scholars most cited alongside Roos E. Barth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roos E. Barth Line = papers co-authored together Roos E. Barth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review PLoS ONE ·Alinda G. Vos, Nikmah S. Idris, Roos E. Barth, Kerstin Klipstein‐Grobusch, Diederick E. Grobbee	2016	86
2	Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa AIDS ·Roos E. Barth, Annemarie M. J. Wensing, Hugo A. Tempelman, Robert Moraba, Rob Schuurman, Andy I. M. Hoepelman	2008	52
3	Accumulation of Drug Resistance and Loss of Therapeutic Options Precede Commonly Used Criteria for Treatment Failure in HIV-1 Subtype-C-Infected Patients Antiviral Therapy ·Roos E. Barth, Susan C. Aitken, Hugo Tempelman, Sibyl P. M. Geelen, Erik M. van Bussel, Andy I. M. Hoepelman, Rob Schuurman, Annemarie M. J. Wensing	2011	45
4	Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa European Journal of Clinical Microbiology & Infectious Diseases ·Roos E. Barth, Jan T. M. van der Meer, Andy I. M. Hoepelman, P. A. Schrooders, David van de Vijver, Sibyl P. M. Geelen, Hugo A. Tempelman	2008	43
5	HIV and risk of cardiovascular disease in sub-Saharan Africa: Rationale and design of the Ndlovu Cohort Study European Journal of Preventive Cardiology ·Alinda G. Vos, Hugo A. Tempelman, W.L.J.M. Devillé, Roos E. Barth, Annemarie M. J. Wensing, Mirjam Kretzschmar, Kerstin Klipstein‐Grobusch, Andy I. M. Hoepelman, Kiki Tesselaar, Sue Aitken, Mashudu Madzivhandila, Cuno Uiterwaal, François Venter, Roel A. Coutinho, Diederick E. Grobbee	2017	27
6	Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review PLoS ONE ·Alinda G. Vos, Annelieke Hulzebosch, Diederick E. Grobbee, Roos E. Barth, Kerstin Klipstein‐Grobusch	2017	19
7	Cardiovascular disease risk in an urban African population: a cross-sectional analysis on the role of HIV and antiretroviral treatment Retrovirology ·Alinda G. Vos, Klariska Hoeve, Roos E. Barth, Joyce Peper, Michelle Moorhouse, Nigel J. Crowther, François Venter, Diederick E. Grobbee, Michiel L. Bots, Kerstin Klipstein‐Grobusch	2019	15
8	The association between HIV infection and pulmonary function in a rural African population PLoS ONE ·Meri R.J. Varkila, Alinda G. Vos, Roos E. Barth, Hugo A. Tempelman, W.L.J.M. Devillé, Roel A. Coutinho, Diederick E. Grobbee, Kerstin Klipstein‐Grobusch	2019	14
9	The Montreal Cognitive Assessment–Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa International Journal of Infectious Diseases ·Charlotte S. Hakkers, Alexandra J.M. Beunders, M.H.M. Ensing, Roos E. Barth, Sarai R. Boelema, W.L.J.M. Devillé, H. Tempelman, R A Coutinho, Andy I. M. Hoepelman, Joop E. Arends, M.J.E. van Zandvoort	2017	14
10	Electrocardiographic and echocardiographic abnormalities in urban African people living with HIV in South Africa PLoS ONE ·Geert V.T. Roozen, Ruchika Meel, Joyce Peper, François Venter, Roos E. Barth, Diederick E. Grobbee, Kerstin Klipstein‐Grobusch, Alinda G. Vos	2021	11
11	Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes Journal of Clinical Virology ·Susan C. Aitken, Aletta Kliphuis, Carole L. Wallis, Mei Ling J. N. Chu, Quirine Fillekes, Roos E. Barth, Wendy Stevens, Tobias F. Rinke de Wit, Rob Schuurman	2012	11
12	Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir Retrovirology ·Alinda G. Vos, Matthew Chersich, Kerstin Klipstein‐Grobusch, Peter Zuithoff, Michelle Moorhouse, Samanta Tresha Lalla‐Edward, Andrew Kambugu, (unknown), Diederick E. Grobbee, Roos E. Barth, François Venter	2018	10
13	The influence of HIV infection and antiretroviral treatment on pulmonary function in individuals in an urban setting in sub-Saharan Africa Southern African Journal of HIV Medicine ·O Berg, Erica Shaddock, Sarah Stacey, Charles Feldman, Roos E. Barth, Diederick E. Grobbee, François Venter, Kerstin Klipstein‐Grobusch, Alinda G. Vos	2021	4
14	Predictors of impaired pulmonary function in people living with HIV in an urban African setting Southern African Journal of HIV Medicine ·Sarah E. van Riel, Kerstin Klipstein‐Grobusch, Roos E. Barth, Diederick E. Grobbee, Charles Feldman, Erica Shaddock, Sarah Stacey, François Venter, Alinda G. Vos	2021	4
15	No Evidence for an Association of HIV and Antiviral Treatment With Changes in Framingham Cardiovascular Risk Score in the Ndlovu Cohort Study Journal of the American Heart Association ·Rita Verstraeten, Alinda G. Vos, Daniel Boateng, Karine Scheuermaier, Hugo A. Tempelman, Roos E. Barth, W.L.J.M. Devillé, Roel A. Coutinho, François Venter, Diederick E. Grobbee, Kerstin Klipstein‐Grobusch	2024	2
16	Comparative performance of cardiovascular risk prediction models in people living with HIV Southern African Journal of HIV Medicine ·Irtiza S. Tahir, Alinda G. Vos, Johanna AAG Damen, Roos E. Barth, Hugo A. Tempelman, Diederick E. Grobbee, Karine Scheuermaier, François Venter, Kerstin Klipstein‐Grobusch	2022	2
17	Trends in body mass index in the pre-dolutegravir period in South Africa Southern African Journal of HIV Medicine ·Florian van Ginkel, Roos E. Barth, Hugo A. Tempelman, Kerstin Klipstein‐Grobusch, Diederick E. Grobbee, Karine Scheuermaier, François Venter, Alinda G. Vos	2024	1
18	Accurate prediction of response to HIV therapy without a genotype: a potential tool for therapy optimization in resource-limited settings Antiviral Therapy ·B. A. Larder, Andrew Revell, D. Wang, Raph L Hamers, H. Tempelman, Roos E. Barth, Annemarie M. J. Wensing, Casey D. Morrow, Robin Wood, A. van Sighem, Peter Reiss, M Nelson, Sean Emery, Julio Montaner, H. C. Lane	2013	1
19	Course of Disease and Clinical Outcome of Infective Endocarditis in HIV-infected Individuals: A Systematic Review and Meta-analysis Alinda G. Vos, Christiaan F J Antonides, J. Bos, Kerstin Klipstein‐Grobusch, Roos E. Barth, Ruchika Meel	2020	1
20	Modelling response to antiretroviral therapy without a genotype as a clinical tool for resource-limited settings Data Archiving and Networked Services (DANS) ·Brendan Larder, Andrew Revell, Daisy Wang, Raph L Hamers, H. Tempelman, Roos E. Barth, Amj Wensing, Carl Morrow, Robin Wood, F. DeWolf, Rolf Kaiser, Anton Pozniak, H. Clifford Lane, Julio Montaner	2011	1

About Roos E. Barth

Roos E. Barth is a scholar working on Infectious Diseases, Emergency Medicine, Epidemiology, Virology and Cardiology and Cardiovascular Medicine, having authored 22 papers that have together received 363 indexed citations. Recurring topics across this work include HIV-related health complications and treatments (12 papers), HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Cardiovascular Disease and Adiposity (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Virology (186 citations), Emergency Medicine (161 citations), Infectious Diseases (231 citations), Epidemiology (78 citations) and Cardiology and Cardiovascular Medicine (43 citations). Roos E. Barth has collaborated with scholars based in Netherlands, South Africa and United States. Frequent co-authors include Kerstin Klipstein‐Grobusch, Diederick E. Grobbee, Alinda G. Vos, Andy I. M. Hoepelman, Hugo A. Tempelman, Nikmah S. Idris, Annemarie M. J. Wensing, Rob Schuurman, Sibyl P. M. Geelen and François Venter. Their work appears in journals such as PLoS ONE, Retrovirology, Antiviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact